Active Health
METASTRA

COMPUTER-AIDED EFFECTIVE FRACTURE RISK STRATIFICATION OF PATIENTS WITH VERTEBRAL METASTASES FOR PERSONALISED TREATMENT THROUGH ROBUST COMPUTATIONAL MODELS VALIDATED IN CLINICAL SETTINGS

€6.7MFunding
60Months
15Partners

Fact sheet

Programme
Horizon Europe & sub-programmes
Companies
EURICE, RISE
Duration
60 months (July 2023 – June 2028)
Project funding
€ 6,750,817.00
Project partners
15
Project website
https://www.metastraproject.eu/

Project contact(s)

Your contact at RISE
Nikolina Lednicki
Communications Manager
Your contact at EURICE
Dr Sanja Šale
Senior Innovation Manager

About the project

METASTRA aims to transform the way clinicians assess fracture risk in cancer patients with vertebral metastases. METASTRA will develop innovative artificial intelligence and Physiology-based (VPH) mechanical computational models to accurately stratify patients with spine metastasis who are at high risk of fractures and identify personalised surgical treatments. The project will integrate the computational models into a user-friendly Decision Support System (DSS) tailored to meet regulatory requirements and future commercialisation opportunities. METASTRA’s innovative guidelines for patient stratification and management are expected to significantly reduce uncertain diagnoses from the current 60% to a mere 20% of cases, potentially saving up to 2.4 billion euros annually in healthcare expenditures.

Coordinator

Professor Luca Cristofolini
Alma Mater Studiorum – Università di Bologna
Email coordinator